Es un tratamiento doloroso
Este frmaco pertenece a una clase conocida como agonistas duales del receptor de GIP (polipptido insulinotrpico dependiente de glucosa) y GLP-1 (pptido similar al glucagn tipo 1)
It also increases energy expenditure, possibly due to increased activity in the sympathetic nervous system and changes in fat metabolism Semaglutide GLP-1 improved insulin sensitivity, increased energy expenditure, fat oxidation, and reduced inflammation can result in significant weight loss and sustained weight management with Semaglutide GLP-1 therapy
Hawkins WG, Busam KJ, Ben-Porat L, Panageas KS, Coit DG, Gyorki DE, et al
Metabolic rate drops by 200 to 500 calories daily beyond what reduced body mass would predict